Advertisement

Allergy

FDA Finalizes Montelukast Black Box Warning

Agency approves label changes after reports of neuropsychiatric events WASHINGTON — The FDA finalized and approved new safety labeling changes for prescription allergy and asthma drug montelukast (Singulair) after reports...

Read More

Advertisement

For latest news and updates
Email-id is invalid